Considering firstly, the GEPIA-verified expression change of MSLN gene in both COAD and READ and secondly, not being MEXPRESS-verified methylation status of this gene and for third, its plausible ROC curve we introduce the hypo-methylation of this gene as a contingent diagnostic marker in colorectal cancer for the first time. Here, MSLN is linked to colorectal cancer.